Bio View (XTAE:BIOV) Price-to-Operating-Cash-Flow : 35.88 (As of May. 28, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Bio View Price-to-Operating-Cash-Flow?

As of today (2024-05-28), Bio View's share price is ₪0.287. Bio View's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.01. Hence, Bio View's Price-to-Operating-Cash-Flow Ratio for today is 35.88.

The historical rank and industry rank for Bio View's Price-to-Operating-Cash-Flow or its related term are showing as below:

XTAE:BIOV' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.4 Med: 17.64 Max: 319.1
Current: 36.38

During the past 13 years, Bio View's highest Price-to-Operating-Cash-Flow Ratio was 319.10. The lowest was 7.40. And the median was 17.64.

XTAE:BIOV's Price-to-Operating-Cash-Flow is ranked worse than
74.2% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 20.5 vs XTAE:BIOV: 36.38

Bio View's Cash Flow from Operations per share for the three months ended in Dec. 2023 was ₪0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Bio View was -85.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -45.00% per year.

During the past 13 years, Bio View's highest 3-Year average Operating Cash Flow per Share Growth Rate was 26.00% per year. The lowest was -45.00% per year. And the median was -19.80% per year.

Bio View Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Bio View's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio View Price-to-Operating-Cash-Flow Chart

Bio View Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

16.88

66.83

14.21

52.81

329.00

Bio View Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	52.81	45.00	-

Competitive Comparison of Bio View's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Bio View's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio View's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio View's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bio View's Price-to-Operating-Cash-Flow falls into.

Bio View Price-to-Operating-Cash-Flow Calculation

Bio View's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.287	/	0.008
	=	35.88

Bio View's Share Price of today is ₪0.287.
Bio View's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Bio View Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bio View's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio View (XTAE:BIOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio View Ltd (XTAE:BIOV) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Pekeris Street, Rehovot, ISR, 7670203

Website

http://www.bioview.co.il

Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.

Bio View (XTAE:BIOV) Headlines

No Headlines